Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
Clinical trial NCT06785415 · RECRUITING
Trial details
- NCT number
- NCT06785415
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2031-04-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.